Purchase Order 75N95019P00599
- Not listed
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, to Metabolon, Inc., a self-certified small disadvantaged business, for other functions metabolic analyses of art samples. The potential value of the contract is $51,060.00, with a completion date of October 31, 2017. Metabolon is a leading provider of metabolomics solutions, offering analytical methods...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $177,991.20 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic profiling of individuals of African descent. The order was issued directly under a solicitation, without the use of a set-aside. Metabolon provides metabolomics services and solutions to government agencies, leveraging its proprietary technology...
- This firm fixed price purchase order contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Metabolon, Inc., a self-certified small disadvantaged business. The $124,800 contract is for a project titled "The Effect of Pre-Analytical Conditions on Metabolite Stability in Urine." Metabolon is a leading provider of metabolomics solutions and has served as both a prime contractor and subcontractor on...
- This is a $9,800 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract supports specialized metabolomics analysis services for various research programs, including those focused on veteran health, precision medicine, and environmental health impacts. Metabolon has been awarded multiple prime contracts and...
- This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Metabolon, Inc., a small disadvantaged business, to provide specialized metabolomics analysis services. The $22,080.00 contract has a period of performance ending on September 22, 2024. Metabolon has served as a prime contractor on numerous federal contracts, providing metabolic profiling of biological samples to support research initiatives across agencies such as the...
- The NIH Clinical Center awarded a $24,784 firm fixed-price purchase order to Metabolon, Inc. for metabolomics analysis services. The contract, which commenced on September 9, 2025, with an ultimate completion date of September 8, 2026, represents a task order under Metabolon's existing Indefinite Delivery Contract with the NIH Clinical Center valued at $250,000. No set-aside designation was utilized for this award. Metabolon, a self-certified small disadvantaged business headquartered in...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $15,000.00 contract is for the collection and analysis of 48 24-hour urine samples from a low-calorie-low-fat (LCLF) diet intervention study. Metabolon, a leading provider of metabolomics services, will leverage its proprietary analytical platforms to identify and quantify metabolites...
- This federal contract award to Metabolon, Inc., a self-certified small disadvantaged business, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $9,000 firm fixed-price purchase order does not have a set-aside designation. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker discovery in drug development and life sciences research. This award...
- This is a $17,000 federal purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Metabolon, Inc., a small disadvantaged business, for metabolite analysis services. The contract is not set aside. Metabolon is a leading provider of metabolomics solutions that leverages proprietary technology to identify and quantify metabolites from biological samples. This contract supports NIDDK's research initiatives, such as the analysis of serum...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $195,000.00 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for the analysis of the metabolome of human pluripotent stem cells and their differentiated progeny. The contract does not have a set-aside designation. Metabolon provides metabolomics services and solutions to federal agencies like the Department of Veterans Affairs, NIH, Food and Drug Administration, and Department of Defense to support research in areas such as veteran health, precision medicine, drug safety, and military medicine. The company holds various indefinite delivery contracts with federal agencies and has also provided metabolomics services as a subcontractor on university-led biomedical research grants.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($195k) | 4/10/24 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 6/16/22 | |
| Not listed | Not listed | $195.0k | 9/6/19 |